Janel FY26 Q3 net income more than doubled to $2.54 million; revenue rises 37.4% to $67.51 million

JANL•2026-08-07

Segment performance and management commentary

Life Sciences operating income fell to USD 538,000, while Manufacturing operating income eased to USD 464,000.

Management cited higher freight rates, increased demand tied to tariff policy changes, and lower Life Sciences demand from larger commercial customers.

Quarterly results rise on stronger logistics demand

Janel released quarterly results for the period ended June 30, 2026, with net income attributable to shareholders rising to USD 2.1 million.

Diluted EPS climbed to USD 1.63, while revenue increased 37.4% to USD 67.51 million versus the prior-year quarter.

Operating income rose to USD 3.64 million, with Logistics segment operating income more than doubled to USD 5.51 million on revenue up 41.3% to USD 61.08 million.

Sources

Janel FY26 Q3 net income more than doubled to $2.54 million; revenue rises 37.4% to $67.51 million

Sec

Janel FY26 Q3 net income more than doubled to $2.54 million; revenue rises 37.4% to $67.51 million

Segment performance and management commentary

Quarterly results rise on stronger logistics demand

Related News

Absci files Form 3 for CMO, Head of R&D Somaratne Ransi Mudalinayake

MGP Ingredients amends Wells Fargo-led credit agreement to add back up to $20 million in receivables losses to EBITDA through 2027

Cohen & Co EVP, CFO and Treasurer Joseph W. Pooler Jr disposes of 8,795 common shares worth $103,970.25

Sources

Janel FY26 Q3 net income more than doubled to $2.54 million; revenue rises 37.4% to $67.51 million

Block CFO and COO Amrita Ahuja disposes of $770,219 of common shares

Porch Group CFO Shawn Tabak sells 25,000 shares for $405,158